| Literature DB >> 28849572 |
Yann Duchartre1, Yong-Mi Kim1, Michael Kahn2,3.
Abstract
Wnt (Wingless-related integration site)-signaling orchestrates self-renewal programs in normal somatic stem cells as well as in cancer stem cells. Aberrant Wnt signaling is associated with a wide variety of malignancies and diseases. Although our understanding has increased tremendously over the past decade, therapeutic targeting of the dysregulated Wnt pathway remains a challenge. Here we review recent preclinical and clinical therapeutic approaches to target the Wnt pathway.Entities:
Keywords: Cancer stem cells; Clinical trial; Drug resistance; Self-renewal; Somatic stem cells; Wnt signaling
Mesh:
Substances:
Year: 2017 PMID: 28849572 PMCID: PMC7473415 DOI: 10.1007/978-1-4939-7027-8_18
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745